A Trial of AK104 Plus Anlotinib in NSCLC
Clinical trial NCT04646330 · COMPLETED
Trial details
- NCT number
- NCT04646330
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2023-10-26
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.